Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

C Han, DW Robinson, MV Hackett… - The Journal of …, 2006 - jrheum.org
OBJECTIVE: To compare the prevalence of cardiovascular diseases and their risk factors
between patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing …

Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: results from the …

…, M Schiff, D Baker, C Han, J Han… - Arthritis & …, 2006 - Wiley Online Library
Han, and Bala own stock or have stock options in Johnson & … Han, and Bala own stock or
have stock options in Johnson & … Han, and Bala own stock or have stock options in Johnson & …

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the …

JS Smolen, C Han, DMFM van der Heijde… - Annals of the …, 2009 - ard.bmj.com
Objective: To examine the association of radiographic progression and disease activity states
in patients with rheumatoid arthritis (RA) treated with methotrexate with or without infliximab…

[HTML][HTML] Guselkumab for the treatment of Crohn's disease: induction results from the phase 2 GALAXI-1 study

…, ME Frustaci, Z Yang, OJ Adedokun, C Han… - Gastroenterology, 2022 - Elsevier
Background & Aims Guselkumab, a selective p19 interleukin-23 antagonist, is approved for
the treatment of plaque psoriasis and psoriatic arthritis. This study evaluated the efficacy and …

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: results from a …

RG Langley, SR Feldman, C Han, B Schenkel… - Journal of the American …, 2010 - Elsevier
BACKGROUND: Anxiety, depression, and impaired health-related quality of life (HRQoL)
are common in patients with psoriasis. OBJECTIVE: We sought to analyze the effect of …

Infliximab improves quality of life in patients with Crohn's disease

GR Lichtenstein, M Bala, C Han… - Inflammatory bowel …, 2002 - academic.oup.com
Objective The aim of this study was to assess the effect of infliximab on quality of life in
patients with active Crohn's disease (CD) inadequately responsive to concomitant therapies. …

[HTML][HTML] Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: results from the VOYAGE 1 and …

…, M Song, B Randazzo, S Li, YK Shen, C Han… - Journal of the American …, 2020 - Elsevier
Background Long-term maintenance treatment is required for patients with psoriasis. Objectives
To evaluate the efficacy and safety of guselkumab in patients with moderate to severe …

Microplastisphere may induce the enrichment of antibiotic resistance genes on microplastics in aquatic environments: a review

X Yu, Y Zhang, L Tan, C Han, H Li, L Zhai, W Ma… - Environmental …, 2022 - Elsevier
Microplastics have been proven to be hotspots of bacterial pathogens and antibiotic
resistance genes (ARGs). The enrichment of ARGs in microplastisphere, the specific niche for …

Infliximab treatment maintains employability in patients with early rheumatoid arthritis

JS Smolen, C Han, D Van Der Heijde… - Arthritis & …, 2006 - Wiley Online Library
Objective To evaluate the impact of infliximab therapy on the employment status of patients
with early rheumatoid arthritis (RA). Methods Methotrexate (MTX)–naive patients with active …

Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis.

C Han, JH Lofland, N Zhao… - Journal of drugs in …, 2011 - europepmc.org
Objective To characterize the prevalence of psychiatric disorders in patients with moderate-to-severe
psoriasis and compare health care costs between patients with and without …